131 related articles for article (PubMed ID: 27660689)
41. Post-translational protein deimination in cod (Gadus morhua L.) ontogeny novel roles in tissue remodelling and mucosal immune defences?
Magnadóttir B; Hayes P; Hristova M; Bragason BT; Nicholas AP; Dodds AW; Guðmundsdóttir S; Lange S
Dev Comp Immunol; 2018 Oct; 87():157-170. PubMed ID: 29908202
[TBL] [Abstract][Full Text] [Related]
42. Peptidylarginine Deiminases-Roles in Cancer and Neurodegeneration and Possible Avenues for Therapeutic Intervention via Modulation of Exosome and Microvesicle (EMV) Release?
Lange S; Gallagher M; Kholia S; Kosgodage US; Hristova M; Hardy J; Inal JM
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587234
[TBL] [Abstract][Full Text] [Related]
43. Discovery of Novel Potential Reversible Peptidyl Arginine Deiminase Inhibitor.
Aliko A; Kamińska M; Falkowski K; Bielecka E; Benedyk-Machaczka M; Malicki S; Kozieł J; Wong A; Bryzek D; Kantyka T; Mydel P
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052493
[TBL] [Abstract][Full Text] [Related]
44. Deimination of myelin basic protein. 2. Effect of methylation of MBP on its deimination by peptidylarginine deiminase.
Pritzker LB; Joshi S; Harauz G; Moscarello MA
Biochemistry; 2000 May; 39(18):5382-8. PubMed ID: 10820009
[TBL] [Abstract][Full Text] [Related]
45. Autoantibodies to Peptidylarginine Deiminase 2 Are Associated With Less Severe Disease in Rheumatoid Arthritis.
Darrah E; Giles JT; Davis RL; Naik P; Wang H; Konig MF; Cappelli LC; Bingham CO; Danoff SK; Andrade F
Front Immunol; 2018; 9():2696. PubMed ID: 30515171
[No Abstract] [Full Text] [Related]
46. Noncovalent Protein Arginine Deiminase (PAD) Inhibitors Are Efficacious in Animal Models of Multiple Sclerosis.
Tejeda EJC; Bello AM; Wasilewski E; Koebel A; Dunn S; Kotra LP
J Med Chem; 2017 Nov; 60(21):8876-8887. PubMed ID: 29045782
[TBL] [Abstract][Full Text] [Related]
47. Conversion of peanut trypsin-chymotrypsin inhibitor B-III to a chymotrypsin inhibitor by deimination of the P1 arginine residues in two reactive sites.
Kurokawa T; Hara S; Takahara H; Sugawara K; Ikenaka T
J Biochem; 1987 Jun; 101(6):1361-7. PubMed ID: 3667552
[TBL] [Abstract][Full Text] [Related]
48. Reduced glutathione as a physiological co-activator in the activation of peptidylarginine deiminase.
Damgaard D; Bjørn ME; Steffensen MA; Pruijn GJ; Nielsen CH
Arthritis Res Ther; 2016 May; 18(1):102. PubMed ID: 27149996
[TBL] [Abstract][Full Text] [Related]
49. Evolution of S100A3 and PAD3, two important genes for mammalian hair.
Minato T; Unno M; Kitano T
Gene; 2019 Sep; 713():143975. PubMed ID: 31302167
[TBL] [Abstract][Full Text] [Related]
50. Smoking is not linked to the development of anti-peptidylarginine deiminase 4 autoantibodies in rheumatoid arthritis.
Cappelli LC; Konig MF; Gelber AC; Bingham CO; Darrah E
Arthritis Res Ther; 2018 Mar; 20(1):59. PubMed ID: 29566742
[TBL] [Abstract][Full Text] [Related]
51. The Development of Benzimidazole-Based Clickable Probes for the Efficient Labeling of Cellular Protein Arginine Deiminases (PADs).
Nemmara VV; Subramanian V; Muth A; Mondal S; Salinger AJ; Maurais AJ; Tilvawala R; Weerapana E; Thompson PR
ACS Chem Biol; 2018 Mar; 13(3):712-722. PubMed ID: 29341591
[TBL] [Abstract][Full Text] [Related]
52. Peptidylarginine deiminase isoforms 1-3 are expressed in the epidermis and involved in the deimination of K1 and filaggrin.
Nachat R; Méchin MC; Takahara H; Chavanas S; Charveron M; Serre G; Simon M
J Invest Dermatol; 2005 Feb; 124(2):384-93. PubMed ID: 15675958
[TBL] [Abstract][Full Text] [Related]
53. The human peptidylarginine deiminases type 2 and type 4 have distinct substrate specificities.
Assohou-Luty C; Raijmakers R; Benckhuijsen WE; Stammen-Vogelzangs J; de Ru A; van Veelen PA; Franken KL; Drijfhout JW; Pruijn GJ
Biochim Biophys Acta; 2014 Apr; 1844(4):829-36. PubMed ID: 24594197
[TBL] [Abstract][Full Text] [Related]
54. Peptidylarginine deiminase is involved in maintaining the cornified oral mucosa of rats.
Arita S; Hatta M; Uchida K; Kita T; Okamura K; Ryu T; Murakami H; Sakagami R; Yamazaki J
J Periodontal Res; 2018 Oct; 53(5):750-761. PubMed ID: 29687476
[TBL] [Abstract][Full Text] [Related]
55. Update on peptidylarginine deiminases and deimination in skin physiology and severe human diseases.
Méchin MC; Sebbag M; Arnaud J; Nachat R; Foulquier C; Adoue V; Coudane F; Duplan H; Schmitt AM; Chavanas S; Guerrin M; Serre G; Simon M
Int J Cosmet Sci; 2007 Jun; 29(3):147-68. PubMed ID: 18489346
[TBL] [Abstract][Full Text] [Related]
56. Role for peptidylarginine deiminase enzymes in disease and female reproduction.
Horibata S; Coonrod SA; Cherrington BD
J Reprod Dev; 2012; 58(3):274-82. PubMed ID: 22790870
[TBL] [Abstract][Full Text] [Related]
57. Specificity and mode of action of the muscle-type protein-arginine deiminase.
Nomura K
Arch Biochem Biophys; 1992 Mar; 293(2):362-9. PubMed ID: 1346955
[TBL] [Abstract][Full Text] [Related]
58. Deimination of human myelin basic protein by a peptidylarginine deiminase from bovine brain.
Lamensa JW; Moscarello MA
J Neurochem; 1993 Sep; 61(3):987-96. PubMed ID: 7689646
[TBL] [Abstract][Full Text] [Related]
59. Porphyromonas gingivalis and its LPS differentially regulate the expression of peptidyl arginine deiminases in human chondrocytes.
Elkaim R; Bugueno-Valdebenito IM; Benkirane-Jessel N; Tenenbaum H
Innate Immun; 2017 Jul; 23(5):468-475. PubMed ID: 28633586
[TBL] [Abstract][Full Text] [Related]
60. Cutting Edge: Protein Arginine Deiminase 2 and 4 Regulate NLRP3 Inflammasome-Dependent IL-1β Maturation and ASC Speck Formation in Macrophages.
Mishra N; Schwerdtner L; Sams K; Mondal S; Ahmad F; Schmidt RE; Coonrod SA; Thompson PR; Lerch MM; Bossaller L
J Immunol; 2019 Aug; 203(4):795-800. PubMed ID: 31292215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
